Drug Trial Radar · NCT04123613
Multiple Doses of DM199 in Patients With Chronic Kidney Disease (REDUX)
Last checked: Nov 20, 2026Latest source record: Nov 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
84
Actual
Start
Dec 17, 2019
Primary completion
Mar 16, 2022
Study completion Mar 16, 2022
Sponsor
- Lead sponsor
- DiaMedica Therapeutics IncIndustry
- Sponsor type
- Industry
- First posted
- Oct 11, 2019
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
An open-label, Phase II, multi-center study evaluating multiple doses of DM199 in participants with chronic kidney disease.
Conditions
- Kidney Diseases
Interventions
DM199Drug
A pharmaceutical formulation comprised of recombinant human tissue kallikrein-1 (rhKLK-1) that is being developed as an injectable protein drug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Safety as Assessed by Incidence, Severity and Causality of AEsTime frame: From initial dose (Day 1) through Day 104
- Estimated Glomerular Filtration Rate (eGFR), Change From BaselineTime frame: Baseline, Weeks 2, 4, 6, 8, 10, 12, 14, and 16
- Urine Albumin to Creatinine Ratio (UACR), Change From BaselineTime frame: Baseline, Weeks 2, 4, 6, 8, 10, 12, 14, and 16
- Systolic Blood Pressure, Change From BaselineTime frame: Baseline, Day 4 through Day 95
- Diastolic Blood Pressure, Change From BaselineTime frame: Baseline, Day 4 through Day 95
- Urine KLK1 Concentration Pre and Post DM199 AdministrationTime frame: Baseline through Day 104
- Plasma KLK1 Concentration Pre and Post DM199 AdministrationTime frame: Baseline through Day 104
Locations
14 sites in 1 country. Site status is shown where the registry gives one.
Aventiv Research
Mesa, Arizona
Amicis Research Center
Granada Hills, California
Amicis Reserch Center
Granada Hills, California
IMD Clinical Trials Inc
Los Angeles, California
Innovative Healthcare Institute
Coral Springs, Florida
Elixia at Florida Kidney Physicians-SE
Fort Lauderdale, Florida
Pines Clinical Research-Hollywood
Hollywood, Florida
Elixia at Florida Kidney Physicians
Temple Terrace, Florida
Boise Kidney & Hypertension Institute
Meridian, Idaho
Research by Design LLC
Chicago, Illinois
New Orleans Center for Clinical Research, an AMR Company
New Orleans, Louisiana
Elixia At Clinical Renal Associates
Upland, Pennsylvania
Nephrotex Research Group, LLC
Dallas, Texas
RDRI
DeSoto, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.